CRP and metabolic syndrome: Among 26,016 subjects with MetS, 41.9% and 22.1% had elevated systolic and diastolic blood pressure, respectively, 25.1% had reduced HDL-C, 50.3% had elevated serum TG, 70.1% had abnormal FPG, and 38.8% had elevated CRP (table not shown).